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EDITORIAL
Editorial – ethical practice and genomic research
Genomic research offers the potential of significant improvements in diagnosis, treatment,
and in health care more broadly. The achievement of these benefits against a background
of well-founded public trust and confidence depends crucially upon the addressing of a
range of important ethical challenges such as those related to consent, privacy, ownership
of samples and data sharing (Cambon-Thomsen et al., 2007). More recently, the range of
such issues has expanded to include a number of questions relating to the feedback of
findings, and the appropriate nature of the relationship between genomic research and
medical practice. When genomic studies are conducted in the context of international colla-
borative research and in settings with low literacy levels, such issues arise with even greater
intensity, and are compounded by further challenges (Parker & Kwiatkowski, 2016; Ramsay
et al., 2014). Some of the key issues highlighted in the global heath ethics literature include
how to explain key scientific concepts in lay terms to improve research understanding, the
model of consent that is appropriate for future uses of human biological samples, the value
and place of community engagement, benefit-sharing, ownership and control of samples,
associated data and sample and data sharing, and questions relating to fair collaborations
(de Vries et al., 2011; Munung et al., 2016; Nyika, 2009; Parker et al., 2016; Tindana et al.,
2012; Upshur et al., 2007; Wonkam et al., 2011).
One area of intense debate in recent times has been the model of consent that should be
appropriate for genomic and biobanking studies in low and middle-income countries, and
what type of governance mechanism is required for safeguarding the interest of research par-
ticipants and their communities in such studies. A growing number of empirical studies from
Africa have highlighted the challenges with obtaining and documenting consent in lower and
middle income countries, particularly in sub-Saharan Africa (Bull et al., 2012; Mandava et al.,
2012; Marshall, 2008; Molyneux et al., 2004; Tekola et al., 2009; Tindana et al., 2006). The
literature suggests that recent advances in research, such as genomic studies, may have
further complicated consent processes due to the complex nature of these studies and unfa-
miliarity with the concepts and methodologies involved. One recommendation for addressing
these challenges is exploring innovative ways of explaining complex scientific terms in lay
terms to research participants, including appropriate levels of community engagement
(CE) (Tindana et al., 2012).
Several proposals have been made to address the issue of consent in genomic and biobank-
ing research – including approaches capable of taking seriously both the need for valid
consent and the fact that the specific details of future research to be undertaken on collected
samples and data cannot be known at the time of initial recruitment. The most prominent
amongst these is what is known as ‘broad consent’, a model of consent that can allow the
use of biological samples and associated data both in specific immediate research and in
future research, subject to appropriate governance arrangements. Proponents of broad
consent have argued that this model of consent is legitimate because it is consistent with
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current practices, it respects the autonomy of participants, and the risks involved are minimal
(Fisher & Layman, 2018; Hansson et al., 2006; Helgesson, 2012; Kaye, 2010; Petrini, 2010;
Sheehan, 2011; Staunton et al., 2019). Their argument is that insisting on very specific
informed consent would fail to take seriously the autonomy of those who wish to give
their broad consent and would make much important research non-viable. It would mean,
for example, returning to research participants for re-consent for each new research use of
their data. This, it is argued, presents significant practical challenges and costs which could
together undermine important research that participants would likely want to see take
place. The conditions for legitimising broad consent are that personal details are handled
safely, ‘future’ research is reviewed and approved by an Institutional Review Board (IRB)
or Research Ethics Committee (REC) or by a data and biospecimen access committee with
appropriate representation, and participants are given the opportunity to withdraw at any
time. However, critics of broad consent have argued that it is misleading to ask for partici-
pants’ informed consent for research that is unforeseen and has not been specified in a
research protocol. For these critics, the only form of valid consent is consent for each very
specific research activity.
Public views and perceptions of research with stored samples and biobanking research are
increasingly being reported in high-income countries such as the United States of America
and the United Kingdom and are contributing to the development of regulatory frameworks
(Garrison et al., 2016; Gibbons & Kaye, 2007; IPSOS Mori, 2019; Pace et al., 2006; Steinsbekk
et al., 2013; Wendler & Emanuel, 2002). Much less work of this kind has been undertaken on
the African continent, despite the fact that recent years have seen a rapid growth in genomic
research in many African countries as a result of initiatives such as H3Africa. Some empirical
studies in Africa have reported that although there is general support for genomic studies,
particularly on the reuse of samples, there are also concerns about how the interests of key
stakeholders such as participants (i.e. sample donors) and the broader local communities
from which samples are collected can and should be ascertained and protected. For
example, the findings from a study by Moodley and Singh (2016) suggest that although
research participants in the Western Cape in South Africa support broad consent for reuse
of samples, the majority of the participants expressed a desire to be informed about what
future studies will be conducted on their samples. Igbe and Adebamowo (2012) reported
that participants in Nigeria were generally supportive of sample storage and future uses on
condition that procedures were in place to prevent the unethical use of the specimens col-
lected. In this collection of three papers, we contribute to this growing body of work to
report the views of research participants and other key stakeholders on sample storage and
the securing of consent in genomic research in Zambia, Uganda, and Ghana (Mweemba
et al., 2019; Rutakumwa et al., 2019; Tindana et al. 2020).
The focus of the paper by Mweemba et al. reports on the findings of a qualitative study
with participants recruited for an H3Africa study on rheumatic heart disease in Zambia.
The study, which focused on participants’ views on broad consent, sample and data
sharing, and secondary use studies, found that broad consent tended to be viewed as an accep-
table approach to consent for genomic research as long as the reasons for storing samples and
data for future research were clearly explained at the time of initial consent. Whilst accepting
the idea of broad consent, a subset of interviewees took the view that some limitations on
future uses might be appropriate by, for example, limiting such uses to research into the
same disease as that which motivated original recruitment. The headline finding of the
paper is that broad consent is an appropriate model for genomic research in Africa as long
as appropriate governance is in place overseeing the limits of future research use.
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The focus of the paper by Rutakumwa et al., is broader in focus exploring the view of
Ugandan research participants about the requirements for ethical genomic research in
Uganda. The study suggests that conventional ethics standards and practices may not be
sufficiently responsive to participant and community concerns and interests in addressing
the ethical complexity of the ethical challenges in research. The findings reported in the
paper suggest three areas in which work is required to improve the responsiveness of
genomic research in this regard. These are: the importance of deemphasising the roles of
experts and institutions in consent processes, achieving greater clarity about the timing
and nature of the feedback of health-related findings and updates on project progress, and
more effective support for research participants during and after the study.
Finally, the paper by Tindana et al., reports on interviews with key stakeholders in Ghana
on consent practices in relation both to the genomics research and to the broader practice of
biobanking. The study included interviews with genomics researchers, fieldworkers, labora-
tory staff, and members of ethics committees, in addition to both participants and those
who refused to participate. The paper reports a willingness to participate in research initiat-
ives involving the collection and sharing of samples and data for future research, as long as
there are good governance structures in place and, importantly, that participants receive feed-
back about the progress of the research endeavour as a whole, and about the research uses of
their samples and data. The study findings emphasise the importance of the discussion of
feedback plans at the time of initial consent.
Taken together, these three papers make an important contribution to debates on the
ethics of genomic research in Africa at a time in which the scale of such research is rapidly
increasing in scale, scope, and importance.
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